Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension

Author:

Sitbon Olivier1,Nikkho Sylvia2,Benza Raymond3,Deng Chunqin (CQ)4,Farber Harrison W.5,Gomberg‐Maitland Mardi6,Hassoun Paul7,Meier Christian2,Pepke‐Zaba Joanna8,Prasad Krishna9,Seeger Werner10,Corris Paul A11

Affiliation:

1. Assistance Publique–Hôpitaux de ParisService de PneumologieHôpital BicêtreUniversité Paris‐SudLaboratoire d’Excellence en Recherche sur le Médicament et Innovation ThérapeutiqueLe Kremlin‐BicêtreFrance

2. Bayer AGClinical DevelopmentBerlinGermany

3. The Ohio State UniversityColumbusOHUSA

4. United Therapeutics CorporationRaleigh‐DurhamNCUSA

5. Tufts Medical CenterBostonMAUSA

6. George Washington University of Medicine and Health SciencesWashington, DCUSA

7. Johns Hopkins University School of MedicineBaltimoreMDUSA

8. Royal Papworth Hospital NHS Foundation TrustCambridgeUK

9. Medicines and Healthcare Products Regulatory Agency (MHRA)LondonUK

10. University of Giessen and Marburg Lung Center (UGMLC)GiessenGermany

11. Clinical and Translational Research Institute Newcastle UniversityNewcastle upon TyneUK

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Reference57 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3